thesicktimes.org
Experimental peptides are being advertised for Long COVID. But the evidence is trailing behind. - The Sick Times
Some FDA-approved GLP-1s are being studied in clinical trials for the disease, but their results aren’t available yet. Experts caution against using experimental peptides for Long COVID.
Leggi l'articolo su thesicktimes.org